Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids
Authors:
- 22 August 2019
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 35 (11) , 1925-1935
Abstract
Objective: To perform a retrospective, matched-cohort, longitudinal evaluation of annual pre- and post-diagnosis costs incurred among women with uterine fibroids (UF) (cases) compared to controls without UF. Methods: Data were derived from the IBM Watson Health MarketScan Commercial Claims and Encounters and Medicaid Multi-State databases. Women aged 18–64 years with ≥1 inpatient or outpatient medical claim with an initial UF diagnosis (index date) from 1 January 2010 to 31 December 2014 were included. Healthcare resource utilization (HCRU) data including pharmacy, outpatient and inpatient hospital claims were collected for 1 year pre-index and ≤5 years post-index. All-cause costs (adjusted to 2017 $US) were compared between cases and controls using multivariable regression models. Results: Analysis included 205,098 (Commercial) and 24,755 (Medicaid) case–control pairs. HCRU and total all-cause healthcare costs were higher for cases versus controls during the pre-index year and all years post-index. Total unadjusted mean all-cause costs were $1197 higher (p < .0001; Commercial) and $2813 higher (standardized difference 0.08; Medicaid) for cases during the pre-index year. Total adjusted mean all-cause costs in the first year post-index were $14,917 for cases versus $5717 for controls in the Commercial population, and $20,244 versus $10,544, respectively, in the Medicaid population. In Years 2–5 post-index, incremental mean adjusted total costs decreased, but remained significantly higher for cases versus controls at all time points in both populations (all p < .05). Conclusions: Costs were higher for women with UF compared to women without UF during the pre-index year and over 5 years post-index; differences were greatest in the first year post-index.Keywords
This publication has 16 references indexed in Scilit:
- The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013American Journal of Obstetrics and Gynecology, 2015
- Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosisCurrent Medical Research and Opinion, 2015
- Uterine FibroidsNew England Journal of Medicine, 2015
- The estimated annual cost of uterine leiomyomata in the United StatesAmerican Journal of Obstetrics and Gynecology, 2012
- Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trendsAmerican Journal of Obstetrics and Gynecology, 2011
- Quality of Care Associated with Common Chronic Diseases in a 9-State Medicaid Population Utilizing Claims Data: An Evaluation of Medication and Health Care Use and CostsPopulation Health Management, 2011
- Inpatient hospitalization for gynecologic disorders in the United StatesAmerican Journal of Obstetrics and Gynecology, 2010
- ACOG Practice Bulletin No. 96: Alternatives to Hysterectomy in the Management of LeiomyomasObstetrics & Gynecology, 2008
- Characterization of therapy and costs for patients with uterine fibroids in Utah MedicaidArchives of Gynecology and Obstetrics, 2007
- Annual Costs Associated With Diagnosis of Uterine LeiomyomataObstetrics & Gynecology, 2006